On June 1, 2021, the European Commission (EU) submitted Circular G/TBT/N/EU/803 to the World Trade Organization (WTO), proposing to include resorcinol (CAS: 108-46-3) in the SVHC List, the time for public consultation is 60 days after the announcement, and the deadline is July 31, 2021.

In March 2020, resorcinol was listed in ECHA's 23rd Critical Substance due to its "endocrine disrupting properties (Article 57(f)-human health)", and the SVHC list published in June 2020 , Due to the failure of the Member State Committee to reach an agreement, resorcinol was not officially included in the SVHC list. Regarding its endocrine disrupting properties, resorcinol has once again become an SVHC review substance, and it is proposed to be included in the SVHC list as the 26th batch in the fourth quarter of 2021.

Reminder:

The SVHC list is updated twice a year. With the continuous update of the SVHC list, companies are facing more and more control requirements. Enterprises need to improve their own product risk awareness. Within six months after the substance is included in the SVHC list, eligible enterprises need to complete the SVHC notification in the article. Starting from January 5, 2021, item suppliers are required to submit SCIP notifications of SVHC related information contained in items to ECHA. ZRLK advises companies to investigate the supply chain as soon as possible to calmly respond to changes in regulations.